Biotricity, Inc.
BTCY
$0.6368
$0.00641.02%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -672.00K | -1.94M | -1.23M | -1.56M | -3.69M |
| Total Depreciation and Amortization | 1.50K | 411.00K | 1.50K | 1.50K | 1.50K |
| Total Amortization of Deferred Charges | 153.60K | 164.10K | 291.10K | 339.90K | 1.14M |
| Total Other Non-Cash Items | 133.60K | 1.52M | 175.90K | 126.90K | 901.20K |
| Change in Net Operating Assets | 10.00K | -559.60K | 672.60K | 696.40K | 152.80K |
| Cash from Operations | -373.40K | -400.80K | -88.10K | -397.10K | -1.49M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 441.60K | 497.10K | 713.20K | 344.70K | -- |
| Total Debt Repaid | -- | -326.00K | -282.40K | -287.50K | -557.60K |
| Issuance of Common Stock | -- | 0.00 | -- | 0.00 | 125.20K |
| Repurchase of Common Stock | -- | -- | 0.00 | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 0.00 | 420.00K | 1.31M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.90K | -6.10K | -5.90K | -6.00K | -12.00K |
| Other Financing Activities | -- | 0.00 | 0.00 | -- | -- |
| Cash from Financing | 435.70K | 165.00K | 425.00K | 471.10K | 868.20K |
| Foreign Exchange rate Adjustments | -36.20K | 91.30K | -500.00 | -1.50K | -59.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.10K | -144.50K | 336.30K | 72.50K | -685.30K |